T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
2 clinical trials · Condition
◉ Watch T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
| Record | Firm | Date |
|---|---|---|
| Duodenal pulsENDO as an Early Treatment for Type 2 DM (NCT07376486) | Chinese University of Hong Kong | 2026-09-01 |
| A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients (NCT02279407) | AstraZeneca | 2015-01-01 |
Track T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin) automatically
Every clearance here is in the API, with alerts when new ones post.